Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-001923-53-ES
EUCTR2014-001923-53-ES
Active, not recruiting
Not Applicable

Intravenous iron, early functional recovery and deliriumin patients atients with hip fracture

Rafael Bielza Galindo0 sitesJuly 10, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHip fractureMedDRA version: 18.0Level: PTClassification code 10020100Term: Hip fractureSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
DrugsHIERRO SACAROSA NORMONSalina Fisiologica Grifols

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip fracture
Sponsor
Rafael Bielza Galindo
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Rafael Bielza Galindo

Eligibility Criteria

Inclusion Criteria

  • •Patients included in the study with hip fracture
  • •osteoporotic treated in our unit, with the following characteristics:
  • •Age over 75 years
  • •Having borrowed agreed to participate in the study by signing the
  • •corresponding Informed Consent Document.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • •Hypersensitivity to oral or parenteral preparations of iron.
  • •Asthma or other severe atopy.
  • •Withdrawal of informed consent.
  • •No indication of surgical fracture

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer.Iron-deficiency in colorectal cancerMedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-003819-56-DKCentre for Surgical Science134
Recruiting
Phase 1
Iron therapy for very low birth weight infants
CTRI/2013/01/003277JIPMER Institute Research Grant112
Terminated
Phase 3
The role of intravenous iron for patients with anaemia around the time of surgery
ACTRN12611000387921yell McEwin Hospital136
Active, not recruiting
Phase 1
Effect of intravenous replenishment of iron in preoperative management of anemia in patients with colon cancer: RIPAC-trial
EUCTR2018-004213-41-BEniversity Hospital Ghent60
Active, not recruiting
Phase 1
Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. - Intravenous Iron: measuring response in anaemic surgical patientsAnaemia (specifically related to surgical pathology)
EUCTR2009-011382-80-GBottingham University Hospital20